US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black Diamond

6.65

+0.05000.76%

Volume:225.45K

Turnover:1.50M

Market Cap:199.61M

PE:-22.93

High:6.75

Open:6.65

Low:6.40

Close:6.60

Loading ...

Overview Company News Filings

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Black Diamond’s Earnings Call: Growth Amid Challenges

Black Diamond Therapeutics Reports 2024 Financial Results

Black Diamond Therapeutics price target lowered to $15 from $16 at Stifel

Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating

MT Newswires Live

Black Diamond: Q4 Earnings Snapshot

Associated Press Finance

Black Diamond Therapeutic Q4 EPS $(0.28) Beats $(0.31) Estimate

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Black Diamond Increases Stake in Emeco Holdings

Black Diamond Group Initiates Automatic Share Purchase Program

Black Diamond Group to Present at Investor Conference

Black Diamond Theraptcs Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Promising Clinical Outcomes and Financial Stability Support Buy Rating for Black Diamond Therapeutics

Strong Buy Rating for Black Diamond Therapeutics Driven by Financial Stability and Promising Clinical Developments

Black Diamond: Q3 Earnings Snapshot

Associated Press Finance

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Black Diamond Therapeutic's Cash, Cash Equivalents, And Investments Of $112.7M As Of September 30, 2024; Expected To Be Sufficient To Fund Operations Into Q2 Of 2026

Black Diamond Therapeutic Q3 2024 GAAP EPS $(0.28) Beats $(0.38) Estimate

Black Diamond Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BDE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BDE\",,,,,undefined,":{"symbol":"BDE","market":"US","secType":"STK","nameCN":"Black Diamond","latestPrice":6.65,"timestamp":1502481600000,"preClose":6.6,"halted":4,"volume":225449,"delay":0,"floatShares":23980000,"shares":30016000,"eps":-0.29,"marketStatus":"Delisted","change":0.05,"latestTime":"04-04 08:02:16 EDT","open":6.65,"high":6.75,"low":6.4,"amount":1499235.85,"amplitude":0.05303,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.29,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743773400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":6.6,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BDE\",,,,,undefined,":{"symbol":"BDE","floatShares":23980000,"roa":"--","roe":"--","lyrEps":0,"shares":30016000,"dividePrice":0,"high":6.75,"amplitude":0.05303,"preClose":6.6,"low":6.4,"week52Low":4.41,"pbRate":"1.25","week52High":7.15,"institutionHeld":0.9377,"latestPrice":6.65,"eps":-0.29,"divideRate":0,"volume":225449,"delay":0,"ttmEps":-0.29,"open":6.65},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523945652","title":"Black Diamond Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2523945652","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523945652?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., March  31, 2025  (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052225/0/en/Black-Diamond-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BDTX","BDE","LENZ"],"gpt_icon":0},{"id":"2518738133","title":"Black Diamond’s Earnings Call: Growth Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2518738133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518738133?lang=en_us&edition=fundamental","pubTime":"2025-03-11 08:12","pubTimestamp":1741651968,"startTime":"0","endTime":"0","summary":"Black Diamond (BDI) (($TSE:BDI)) has held its Q4 earnings call. Read on for the main highlights of the call. Black Diamond’s recent earnings call p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/black-diamonds-earnings-call-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/black-diamonds-earnings-call-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDE"],"gpt_icon":0},{"id":"2517490797","title":"Black Diamond Therapeutics Reports 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517490797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517490797?lang=en_us&edition=fundamental","pubTime":"2025-03-08 12:01","pubTimestamp":1741406487,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics, Inc. ( ($BDTX) ) has released its Q4 earnings. Here is a breakdown of the information Black Diamond Therapeutics, Inc. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/black-diamond-therapeutics-reports-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/black-diamond-therapeutics-reports-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDTX","BDE","LENZ","BK4139"],"gpt_icon":0},{"id":"2517343910","title":"Black Diamond Therapeutics price target lowered to $15 from $16 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2517343910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517343910?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:25","pubTimestamp":1741357552,"startTime":"0","endTime":"0","summary":"Stifel lowered the firm’s price target on Black Diamond Therapeutics (BDTX) to $15 from $16 and keeps a Buy rating on the shares. The firm updated ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/black-diamond-therapeutics-price-target-lowered-to-15-from-16-at-stifel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/black-diamond-therapeutics-price-target-lowered-to-15-from-16-at-stifel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDTX","BDE","LENZ","SF"],"gpt_icon":0},{"id":"2517812414","title":"Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517812414","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517812414?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:13","pubTimestamp":1741349616,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics (BDTX) has an average rating of Buy and mean price target of $14.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDE","BDTX","LENZ"],"gpt_icon":0},{"id":"2517114958","title":"Black Diamond: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2517114958","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517114958?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:09","pubTimestamp":1741295355,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass.  — CAMBRIDGE, Mass.  — Black Diamond Therapeutics, Inc.  on Thursday reported a loss of $16 million in its fourth quarter.On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 28 cents.The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.For the year, the company reported that its loss narrowed to $69.7 million, or $1.27 per share.In the final minutes of trading on Thursday, the company's shares hit $1.90. A year ago, they were trading at $4.42.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/black-diamond-q4-earnings-snapshot-210915652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BDTX","BDE"],"gpt_icon":0},{"id":"2517711810","title":"Black Diamond Therapeutic Q4 EPS $(0.28) Beats $(0.31) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517711810","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517711810?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:03","pubTimestamp":1741295019,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 17.65 percent increase over losses of $(0.34) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44179260/black-diamond-therapeutic-q4-eps-0-28-beats-0-31-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDE","BDTX"],"gpt_icon":0},{"id":"2517115171","title":"Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2517115171","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517115171?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:01","pubTimestamp":1741294860,"startTime":"0","endTime":"0","summary":"Clinical data on track for Q2 2025 in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLCExpansion of investigator sponsored “window of opportunity” trial into newly diagnosed gli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/06/3038593/0/en/Black-Diamond-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BDE","BDTX","LENZ"],"gpt_icon":0},{"id":"2516525573","title":"Black Diamond Increases Stake in Emeco Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2516525573","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516525573?lang=en_us&edition=fundamental","pubTime":"2025-03-03 07:48","pubTimestamp":1740959329,"startTime":"0","endTime":"0","summary":"Emeco Holdings Limited ( ($AU:EHL) ) has shared an update. Emeco Holdings Limited has announced a change in the substantial holding of shares by Bl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/black-diamond-increases-stake-in-emeco-holdings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/black-diamond-increases-stake-in-emeco-holdings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDE"],"gpt_icon":0},{"id":"2503804665","title":"Black Diamond Group Initiates Automatic Share Purchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2503804665","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503804665?lang=en_us&edition=fundamental","pubTime":"2025-01-14 00:35","pubTimestamp":1736786129,"startTime":"0","endTime":"0","summary":"An update from Black Diamond ( ($TSE:BDI) ) is now available. Black Diamond Group Limited has initiated an automatic share purchase plan (ASPP) as ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/black-diamond-group-initiates-automatic-share-purchase-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/black-diamond-group-initiates-automatic-share-purchase-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDE"],"gpt_icon":0},{"id":"2483001808","title":"Black Diamond Group to Present at Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2483001808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483001808?lang=en_us&edition=fundamental","pubTime":"2024-11-13 10:02","pubTimestamp":1731463329,"startTime":"0","endTime":"0","summary":"Black Diamond (TSE:BDI) has released an update. Black Diamond Group Limited will be showcasing its business at the Sidoti Virtual Investor Conferen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/black-diamond-group-to-present-at-investor-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/black-diamond-group-to-present-at-investor-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDE"],"gpt_icon":0},{"id":"2481620067","title":"Black Diamond Theraptcs Price Target Maintained With a $11.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2481620067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481620067?lang=en_us&edition=fundamental","pubTime":"2024-11-06 17:59","pubTimestamp":1730887140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BDTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2024 04:59 ET (09:59 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BDE"],"gpt_icon":0},{"id":"2481825566","title":"Promising Clinical Outcomes and Financial Stability Support Buy Rating for Black Diamond Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2481825566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481825566?lang=en_us&edition=fundamental","pubTime":"2024-11-06 00:15","pubTimestamp":1730823325,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Marc Frahm has maintained their bullish stance on BDTX stock, giving a Buy rating today. Marc Frahm’s rating is based on Black Dia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-clinical-outcomes-and-financial-stability-support-buy-rating-for-black-diamond-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-clinical-outcomes-and-financial-stability-support-buy-rating-for-black-diamond-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BDE","BDTX"],"gpt_icon":0},{"id":"2481894986","title":"Strong Buy Rating for Black Diamond Therapeutics Driven by Financial Stability and Promising Clinical Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2481894986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481894986?lang=en_us&edition=fundamental","pubTime":"2024-11-05 23:25","pubTimestamp":1730820310,"startTime":"0","endTime":"0","summary":"Analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics (BDTX – Research Report), retaining the price target ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/strong-buy-rating-for-black-diamond-therapeutics-driven-by-financial-stability-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/strong-buy-rating-for-black-diamond-therapeutics-driven-by-financial-stability-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BDTX","BDE"],"gpt_icon":0},{"id":"2481850245","title":"Black Diamond: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2481850245","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481850245?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:00","pubTimestamp":1730815215,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass.  — CAMBRIDGE, Mass.  — Black Diamond Therapeutics, Inc.  on Tuesday reported a loss of $15.6 million in its third quarter.The Cambridge, Massachusetts-based company said it had a loss of 28 cents per share.The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.The company's shares closed at $2.99. A year ago, they were trading at $1.80.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/black-diamond-q3-earnings-snapshot-140015813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BDTX","BDE"],"gpt_icon":0},{"id":"2481166506","title":"Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2481166506","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481166506?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:00","pubTimestamp":1730811600,"startTime":"0","endTime":"0","summary":"Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, and C797S resistance mutations in September 2024. Presented real-world treatment practices and patient outcomes in newly diagnosed NSCLC patients with non-classical EGFR mutations at the 2024 ESMO Congress. Clinical updates of BDTX-1535 in EGFRm NSCLC and regulatory feedback expected in Q1 2025. Cash, cash equivalents, and investments of $112.7 million as of September30, 2024; expected to be sufficient to fund operations into Q2 of 2026. In September 2024, Black Diamond presented a poster analyzing real-world treatment outcomes for newly diagnosed NSCLC patients with non-classical EGFR mutations  at the 2024 European Society for Medical Oncology  Congress. The analyses revealed the presence of a broad spectrum of NCMs, including PACC mutations, and allowed association with real-world treatment practices and therapeutic outcomes. Findings furt","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BXvxt76gxDkYRmwEchGbew--~B/aD0yNTc7dz04Njc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/518a8bb61ba367794514902f3e7e8df5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BXvxt76gxDkYRmwEchGbew--~B/aD0yNTc7dz04Njc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/518a8bb61ba367794514902f3e7e8df5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/black-diamond-therapeutics-reports-third-130000914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PR","BK4213","BDE","LENZ","BDTX"],"gpt_icon":0},{"id":"2481570538","title":"Black Diamond Therapeutic's Cash, Cash Equivalents, And Investments Of $112.7M As Of September 30, 2024; Expected To Be Sufficient To Fund Operations Into Q2 Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2481570538","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481570538?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:10","pubTimestamp":1730808652,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutic's Cash, Cash Equivalents, And Investments Of $112.7M As Of September 30, 2024; Expected To Be Sufficient To Fund Operations Into Q2 Of 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/24/11/41741282/black-diamond-therapeutics-cash-cash-equivalents-and-investments-of-112-7m-as-of-september-30-202","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDE","BDTX","BK4139"],"gpt_icon":0},{"id":"2481570582","title":"Black Diamond Therapeutic Q3 2024 GAAP EPS $(0.28) Beats $(0.38) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481570582","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481570582?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:10","pubTimestamp":1730808632,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.38) by 26.32 percent. This is a 37.78 percent increase over losses of $(0.45) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41741266/black-diamond-therapeutic-q3-2024-gaap-eps-0-28-beats-0-38-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDE","BDTX"],"gpt_icon":0},{"id":"2480884682","title":"Black Diamond Therapeutics Inc    expected to post a loss of 37 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884682","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480884682?lang=en_us&edition=fundamental","pubTime":"2024-11-01 22:09","pubTimestamp":1730470159,"startTime":"0","endTime":"0","summary":"* Black Diamond Therapeutics Inc     is expected to show no change in quarterly revenue when it reports  results on November 4 (estimated) for the period ending September 30 2024   *    * LSEG's mean ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDE","LENZ","BDTX"],"gpt_icon":0},{"id":"2480002548","title":"Black Diamond Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2480002548","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480002548?lang=en_us&edition=fundamental","pubTime":"2024-11-01 20:00","pubTimestamp":1730462400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Nov. 01, 2024  -- Black Diamond Therapeutics, Inc. , a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced its participation in upcoming investor conferences. Presentation details with President and Chief Executive Officer, Mark Velleca, M.D., Ph.D., are as follows:. Stifel Healthcare Conference fireside chat at 4:10pm ET on Tuesday, November 19, 2024. Piper Sandler 36th Annual Healthcare Conference fireside chat at 3:00pm ET on Wednesday, December 4, 2024","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BXvxt76gxDkYRmwEchGbew--~B/aD0yNTc7dz04Njc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/518a8bb61ba367794514902f3e7e8df5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BXvxt76gxDkYRmwEchGbew--~B/aD0yNTc7dz04Njc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/518a8bb61ba367794514902f3e7e8df5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/black-diamond-therapeutics-participate-upcoming-120000585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BDE","BK4139","BDTX","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-05-07","symbol":"BDE","amount":0.025,"defaultRemindTime":1620394200000,"name":"黑钻","recordDate":"2021-05-21","payableDate":"2021-05-10","currency":"USD","type":"dividend","dateTimestamp":1620360000000},{"date":"2017-08-14","symbol":"BDE","newSymbol":"CLAR","type":"symbolChange","dateTimestamp":1502683200000},{"market":"US","date":"2017-08-07","symbol":"BDE","fiscalQuarterEnding":null,"expectedEps":-0.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1502078400000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2017-05-08","symbol":"BDE","fiscalQuarterEnding":null,"expectedEps":0.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1494216000000,"reportTimeType":"post","actualEps":0.01},{"market":"US","date":"2017-03-06","symbol":"BDE","fiscalQuarterEnding":null,"expectedEps":0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1488776400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDE\",market:\"US\",,,undefined,":[{"executeDate":"2021-05-07","recordDate":"2021-05-10","paymentDate":"2021-05-21","value":0.025,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BDE\",market:\"US\",delay:false,,,undefined,":{}}}